CVE-2023-28634

GLPI vulnerable to Privilege Escalation from Technician to Super-Admin

Description

GLPI is a free asset and IT management software package. Starting in version 0.83 and prior to versions 9.5.13 and 10.0.7, a user who has the Technician profile could see and generate a Personal token for a Super-Admin. Using such token it is possible to negotiate a GLPI session and hijack the Super-Admin account, resulting in a Privilege Escalation. Versions 9.5.13 and 10.0.7 contain a patch for this issue.

Category

8.8
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.24%
Vendor Advisory github.com
Affected: glpi-project glpi
Published at:
Updated at:

References

Link Tags
https://github.com/glpi-project/glpi/security/advisories/GHSA-4279-rxmh-gf39 vendor advisory
https://github.com/glpi-project/glpi/releases/tag/10.0.7 patch release notes
https://github.com/glpi-project/glpi/releases/tag/9.5.13 patch release notes

Frequently Asked Questions

What is the severity of CVE-2023-28634?
CVE-2023-28634 has been scored as a high severity vulnerability.
How to fix CVE-2023-28634?
To fix CVE-2023-28634, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-28634 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-28634 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-28634?
CVE-2023-28634 affects glpi-project glpi.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.